the critical value of infectious diseases specialists
DESCRIPTION
The Critical Value of Infectious Diseases Specialists. Steven K. Schmitt, MD, FIDSA, FACP Vice Chair, Medicine Institute Cleveland Clinic. Value is central to reform. Conversation in health care reform is focused on Value Critical questions: What value does each specialty contribute? - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/1.jpg)
![Page 2: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/2.jpg)
The Critical Value of Infectious Diseases Specialists
Steven K. Schmitt, MD, FIDSA, FACPVice Chair, Medicine Institute
Cleveland Clinic
![Page 3: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/3.jpg)
Value is central to reformConversation in health care reform is focused on
ValueCritical questions:• What value does each specialty contribute?• Can specialty care actually bend the cost curve?
Value = Quality Cost
![Page 4: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/4.jpg)
ID Specialists Contribute to Achieving “The Triple Aim”
* Institute for Healthcare Improvement. See more information at http://www.ihi.org/offerings/Initiatives/TripleAIM/Pages/default.aspx
![Page 5: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/5.jpg)
Evidence for ID Value• Link between ID interventions and positive
patient outcomes.* • When the attending physician follows ID
recommendations:– Patients are more often correctly diagnosed– Have shorter length of stays– Have fewer complications– Use antibiotics more judiciously
* See supporting literature cited in Schmitt et al. Infectious Diseases Specialty Intervention Is Associated With Decreased Mortality and Lower Healthcare Costs. Clin Infect Dis. (2013) doi: 10.1093/cid/cit610 First published online: September 25, 2013
![Page 6: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/6.jpg)
Objective of New Research: Proof of Value
• To generate more robust data regarding the impact of ID consultation using a national claims database
• Outcomes significant in the health care reform conversation– Mortality– Readmission rate– Length of stay– Resource utilization
![Page 7: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/7.jpg)
Methods
The matched sample included 61,680 ID cases and 65,192 non-ID cases
![Page 8: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/8.jpg)
Results: NO ID vs ID
Abbreviations: ICU, Intensive Care Unit; ACH, Acute care hospital; PAC, Post acute care; OR, odds ratio; %Δ, percent difference.a Only patients with one or more ICU days. b Excludes patients expiring in the hospital.
“Having an ID Specialist involved in the care of a patient with a severe infection will lead to better outcomes”
![Page 9: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/9.jpg)
Results: “Early” vs “Late”
Abbreviations: ICU, Intensive Care Unit; ACH, Acute care hospital; PAC, Post acute care; OR, odds ratio; %Δ, percent difference.a Only patients with one or more ICU days. b Excludes patients expiring in the hospital.
“Early involvement of an ID Specialist in the care of patients with severe infection will lead to better outcomes with lower costs”
![Page 10: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/10.jpg)
Limitations• Measuring hospital mortality may overstate the impact
of ID intervention on mortality• Unobserved reasons for selection of patients to receive
an ID intervention may confound the results • The PSM methodology excludes some of the sickest
people in the ID intervention group, because they had no matches from the non-ID intervention group (patients who were too dissimilar were not included in the analysis)– The results therefore may not fully reflect the impact of ID
interventions, since it did not take the care for these severe cases into account
![Page 11: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/11.jpg)
Implications• ID involvement leads to improved patient outcomes AND
Early ID interventions result in improved outcomes and reduced costs – Patients seen by an ID specialist are
• 9% less likely to die in the hospital• 12% less likely to die post-discharge• Spend 3.7 % less time in the ICU
• These results suggest a critical role for ID consults for select, severe infections
• Consider these results in light of current core measures such as “all-cause” mortality, pneumonia, CLABSI, and CAUTI
![Page 12: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/12.jpg)
Other areas where ID can add value
• ID specialist-led Antimicrobial Stewardship and Diagnostic Stewardship
• Transitions of care for complex infections• Outpatient Parenteral Antimicrobial Therapy (OPAT)• Employee health• Resource management and Microbiology laboratory
oversight• Public health
![Page 13: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/13.jpg)
Infection preventionAn economist’s view
• Scott (2009)– Benefits of prevention:
http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf
![Page 14: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/14.jpg)
Antimicrobial stewardship
• Beardsley et al (2012): costs over 11 years of stewardship program– Average cost savings (drug savings - program
cost): $920,070 to $2,064,441 per year.
Beardsley JR, et al. Infect Control Hosp Epidemiol. 2012 Apr;33(4):398-400.
![Page 15: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/15.jpg)
Infection prevention and antimicrobial stewardship: why ID?• Clinical boots on the ground
– Outbreak detection– Separation of problems from rumors– Management of complex and drug-resistant
infections– Extensive training in infections, antibiotics,
interpretation of microbiologic data
![Page 16: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/16.jpg)
Infection prevention and antimicrobial stewardship: why ID?
• Consult all over hospital: – Accustomed to cross-disciplinary collaboration– Problem-solvers
• Evidence-based and data aware
![Page 17: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/17.jpg)
OPAT transitions and stewardship• Shrestha NK et al (2012): 263 OPAT
consultation requests• Antimicrobial treatment optimization: right drug!
– Parenteral atb’s often not recommended– Change in diagnosis: right disease!– Same provider transition, inpatient to outpatient
setting: right doc!Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM.J Hosp Med. 2012 May-Jun;7(5):365-9.Shrestha NK, Bhaskaran A, Scalera NM, Schmitt SK, Rehm SJ, Gordon SM.Infect Control Hosp Epidemiol. 2012 Apr;33(4):401-4.
![Page 18: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/18.jpg)
OPAT transitions and stewardship• Longitudinal follow-up
– Lab monitoring– First line of communication
• Patients, caregivers– Prevention, amelioration, management of:
• Adverse drug effects• Flares or ID and non-ID conditions• Venous access complications
– Prevention of ED visits and readmissions
![Page 19: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/19.jpg)
Utilization of other key resources
• Diagnostic Stewardship and Appropriate use– Lab testing– Microbiology lab– Radiology
![Page 20: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/20.jpg)
Population Health
Response Management• Exposures
– Infected healthcare worker– Vaccine-preventable
diseases– TB diagnosis, management,
and prevention• Bioterrorism and natural
disasters
Communications• Internal
– Development of policy and guidance
• External– Providing conduit to local
and state health departments
![Page 21: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/21.jpg)
Innovation by collaboration on value
• Gain-sharing agreements• Co-management services
agreements• Please come to talk tomorrow:
Dr. Ron Nahass
![Page 22: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/22.jpg)
Put us to work for you
• ID ready to collaborate with you as the system evolves in an era of transparency, measurement, and value-based payment
![Page 23: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/23.jpg)
What does ID bring to your team?• Combination of clinical and epidemiologic
expertise– Improved clinical outcomes:
• Save lives!• Save your reputation!
– Prevention of hospital-acquired infection• CLABSI, CAUTI, SSI = $• Reportable measures, pay for performance
– Population health
![Page 24: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/24.jpg)
What does ID bring to your team?
• Improved resource use• Improved care transitions• Collaborative skill-set• Problem solvers
![Page 25: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/25.jpg)
Back-Up Slides
![Page 26: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/26.jpg)
Propensity Score Matching 0
12
34
De
nsity
0.2 0.60.4 0.80.0 1.0Pr(ID Consult)
No ID PS DensityID PS Density
Kernel density estimate of ID Consult Propensity Score, by ID/No ID
ID vs No ID Paired Cases via PSM
![Page 27: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/27.jpg)
ID plays a leading role in health care systems
• Core measures such as pneumonia, CLABSI, CAUTI-maximize reimbursement and save lives!
• Antimicrobial stewardship programs - reduce drug costs and curtail resistance!
• Infection prevention - save lives and reduce costs!• Care transitions - right diagnosis, right drugs, effective
follow-up in outpatient parenteral antibiotic programs.
![Page 28: The Critical Value of Infectious Diseases Specialists](https://reader035.vdocuments.net/reader035/viewer/2022062323/568161e8550346895dd21607/html5/thumbnails/28.jpg)
Put us to work for you!